- Home
- RMCF vs LSTA Comparison
RMCF vs LSTA Comparison
Compare RMCF & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | LSTA |
|---|---|---|
| Founded | 1981 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Misc Health and Biotechnology Services |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 15.9M |
| IPO Year | 2024 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RMCF | LSTA |
|---|---|---|
| Price | $0.88 | $1.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 87.5K | ★ 89.7K |
| Earning Date | 10-19-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.88 | 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | $30,432,352.00 | ★ $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | $0.66 | $0.96 |
| 52 Week High | $2.99 | $5.07 |
Technical Indicators
Market Signals| Indicator | RMCF | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 50.12 | 40.57 |
| Support Level | $0.81 | $0.97 |
| Resistance Level | $1.19 | $1.28 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 45.75 | 42.43 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.